Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amylyx Pharmaceuticals (AMLX) Finished Goods (2022)

Historic Finished Goods for Amylyx Pharmaceuticals (AMLX) over the last 1 years, with Q4 2022 value amounting to $937000.0.

  • Amylyx Pharmaceuticals' Finished Goods changed N/A to $937000.0 in Q4 2022 from the same period last year, while for Dec 2022 it was $937000.0, marking a year-over-year change of. This contributed to the annual value of $937000.0 for FY2022, which is N/A changed from last year.
  • As of Q4 2022, Amylyx Pharmaceuticals' Finished Goods stood at $937000.0.
  • Amylyx Pharmaceuticals' 5-year Finished Goods high stood at $937000.0 for Q4 2022, and its period low was $110000.0 during Q3 2022.